Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03072355
Other study ID # PP1
Secondary ID
Status Completed
Phase N/A
First received February 16, 2017
Last updated November 8, 2017
Start date May 1, 2017
Est. completion date August 30, 2017

Study information

Verified date November 2017
Source São Paulo State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Introduction: The exercise performed with elastic tools has been appearing in the current scenario as a clinical tool because it presents advantages such as easy handling, low cost and safety. However, its use as an assessment tool, specifically for localized muscular resistance, is reduced and not standardized. In addition, there are no records of the physiological / neurofunctional effects of tests that use such a tool, since it allows a differentiated degree of prescription. Objective: To determine the reliability and reproducibility of a shoulder abduction resistance test in two tools, elastic tube and isokinetic dynamometer. In addition to analyzing the metabolic profile of both comparative order and targeting subsequent training prescription. Method: The study will consist of a sample of 30 participants and will be carried out in 2 stages, 15 participants will perform step 1 and the other 15 will perform step 2. The difference between the steps is the order of the tools used to perform the test . Each stage will consist of 5 sessions (Orientation, Familiarization 1 and 2, Test and Retest). During the test and retest sessions the physiological response of the test will be analyzed. In order to observe the response, will be analyzed the lactic anaerobic parameter (lactate concentration), allelic anaerobic (post-exercise oxygen uptake analysis - EPOC), aerobic parameter (VO2 values) and electromyographic measurements. Will be used the statistical package SPSS Statistics 22.0, Pearson's correlation and their respective confidence intervals will indicate the relationship between the numerical variables and multivariate models will be constructed by means of linear regression. The significance level of 5% will be adopted.


Description:

Tests applied

1RM test The 1 RM test in the elastic band is based on the study by ANDERSEN et al. (2016). Elastic bands of the brand Theraband® CLX (Hygienic, Corporation, Akron, Ohio, USA) with a standard length of 1.47m, ranging from very low to very high strength (yellow, red, green, blue, black, silver, gold). Due to possible changes in the mechanical properties of elastic bands during the initial stretching cycles, all elastics will be pre-stretched 100 times.

Initially the research assistant will instruct the participants to sit on a chair, and place their feet together on the elastic band without shoes. Starting with the least elastic resistance (yellow), the research assistant will instruct the participants to perform a shoulder abduction of a unilateral (dominant) shoulder up to 90 ° and hold such a position for 3 seconds (statically). Thus, participants will have to perform the concentric contraction phase without the help of the research assistant before reaching the static test position. Through visual inspection, the search assistant will control the correct positioning of the movement. Two-minute intervals will be taught between resistance levels until it is not possible for the participant to reach and / or hold the position for 3 seconds. When there is a failure, two more attempts to reach and maintain the desired position will be accomplished. During the essay, the research assistant will provide verbal encouragement. The obtained torque will be calculated by a formula based on the study of ANDERSEN et al. (2016).

Isokinetic muscle strength test For the MVIC test, the participant will be seated with the dominant upper limb on the Biodex System Pro 4 isokinetic dynamometer (Biodex Medical System, Shirley-NY, USA). Prior to the test, the participant will undergo a warm-up consisting of 10 repetitions of concentric contraction of abduction-adduction of the shoulder at 180º / s throughout the range of motion. After the warm-up will be given a two-minute rest break to the start of the MVIC. The CIVM will be considered as the Of torque obtained between three 5 second repetitions of abduction, with the dominant upper limb positioned at 90º horizontal abduction of the shoulder. A two-minute interval between replicates will be administered in order to minimize possible fatigue effects. The participant will be instructed to perform their maximum power performance and will be verbally encouraged by the evaluator in each attempt made. Such protocol is based on the one used by BARONI et al., (2010) for lower limb.

Fatigue Resistance Test (TRF) TRF - Elastic Tube: To perform the fatigue resistance test on the elastic tube the participant will initially be positioned sitting on a chair with their feet together stepping on the elastic band without shoes. He will then perform a 20-second abduction-adduction heating of the shoulder from the neutral position to 90 °. The interval of 2 minutes will then be given to start the TRF. This will consist of performing the maximum of the possible repetition with a load of 50% of the 1RM (1½ second in the concentric phase and 1½ second in the eccentric phase).

TRF - Isokinetic Dynamometer: In order to perform the fatigue resistance test in the isokinetic dynamometer, the participant will initially be positioned with the dominant upper limb attached to the dynamometer by means of the apparatus itself. He will then perform a warm-up of 10 concentric contractions of abduction-adduction of the shoulder at 180º / s throughout the range of movement (0º to 90º). The interval of 2 minutes will then be given to start the TRF. This will consist of performing the maximum possible repetition at 50% of the MVIC at the rate of 60º / s for abduction and 500º / s at the return of the movement.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date August 30, 2017
Est. primary completion date August 30, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- Healthy

- Male gender

- Aged between 18 and 30 years

- Agreement to participate through signed statement of informed consent

Exclusion Criteria:

- Be an alcoholic,

- Consume drugs,

- Consuming tobacco or anti-inflammatory medications in a chronic way,

- Anemia, an inflammatory process, diabetes, cardiovascular disease, and

- an episode of muscle-tendon or osteoarticular injury in the lower limbs and / or spine in the last six months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Elastic Band
Localized muscle resistance test for shoulder
Isokinetic dynamometer
Localized muscle resistance test for shoulder

Locations

Country Name City State
Brazil Carlos Pastre, PhD Presidente Prudente

Sponsors (2)

Lead Sponsor Collaborator
São Paulo State University Coordination for the Improvement of Higher Education Personnel

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in time values It will be divided into two stages. The 30 participants recruited will be randomized to perform the steps, 15 participants will perform step 1 and the other 15 participants will perform step 2. The difference between the participants is between the order of the procedures.
In stage 1 the participants will perform 4 tests, the two tests initially with the device tube elastic the two ends with the isokinetic dynamometer, with 30 minutes interval between tests. For step 2, another 15 participants will perform the same procedures with the order of alternate tools. The change time values will be analyzed for reliability and reproducibility of the test.
1 minute post test
Primary Change in repetitions values It will be divided into two stages. The 30 participants recruited will be randomized to perform the steps, 15 participants will perform step 1 and the other 15 participants will perform step 2. The difference between the participants is between the order of the procedures.
In stage 1 the participants will perform 4 tests, the two tests initially with the device tube elastic the two ends with the isokinetic dynamometer, with 30 minutes interval between tests. For step 2, another 15 participants will perform the same procedures with the order of alternate tools. The change on repetitions values will be analyzed for reliability and reproducibility of the test.
1 minute post test
Secondary Perception of effort Evaluated through the OMNI Resistance Exercise Scale for Perceived Effort 1 minute post test 1, 1 minute post test 2, 1 minute post test 3, 1 minute post test 4.
Secondary Recovery Perception Will be evaluated through the Likert Scale of Recovery Perception, with "one" corresponding to "not recovery" and 10 "fully recovery" 10 minute post test 1, 10 minute post test 2, 10 minute post test 3, 10 minute post test 4.
Secondary Psychological Questionnaire Participants will be instructed to mark a dash on a visual analogue scale of 10 centimeters between two extremes, zero being "least possible" and 10 indicating "most possible" for each classification as previously described Baseline
Secondary Lactate concentration After 10 minutes of rest ([lacR]) and at moments 3, 5, and 7 minutes after the test (to determine the peak lactate concentration ([lacP]), 25 µl of arterialized blood of the patient will be collected in heparinized capillaries. Ear lobe, and discarded in plastic tubes (polyethylene) type Eppendorf (1.5 mL) containing 50 µl of sodium fluoride (NaF - 1%), for later lactacidemia analysis, performed in a lactomer. baseline, 3, 5 and 7 minutes after the first test with both tools (Stage 1 and Stage 2)
Secondary Gas exchange Measurement of gas exchange throughout the test and up to 7 minutes at the end. Time-to-exhaustion analysis and post-exercise oxygen uptake (COPD). Immediately post test up to seven minutes post test
Secondary Electromyographic measurements In addition to the variables related to the strength signal (FP,% AV, TC and TS), and the maximum amplitude in the EMG signal reached at the moment of the electrical stimulation, called M-Wave. 1 minute after the second test with both tools (Stage 1 and Stage 2)
See also
  Status Clinical Trial Phase
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1